Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
American Sickle Cell Anemia Association
DD Bldg. Cleveland ClinicSuite DD1-201
10900 Carnegie Avenue
Cleveland, Ohio, United States
Email Phone Web
The American Sickle Cell Anemia Association (ASCAA) is a 501(c) 3 organization that provides quality and comprehensive services through diagnostic testing, evaluation, counseling and supportive services to individuals and families at risk for Sickle Cell Disease and it’s variants.
The organization currently provides a wide range of services to those individuals and families with either sickle cell trait or variants of the disease itself. Key services include: ongoing follow-up diagnostic testing, counseling, and tracking services for parents with infants who screen positive by the State Laboratory; Family Counseling and Support Services; coordination of medical, social services, education and support for the program’s clientele; teacher education and screening services delivery at upwards of 85 local health fairs. In addition, ASCAA makes outreach to the region’s African American, Hispanic, Mediterranean, and Arab communities for family education and the identification of the incidence of sickle cell disease.
+myBinderRelated Content
-
Preventing Strokes in Children with Sickle Cell Diseasehttps://www.youtube.com/watch?v=k6h7cb7S...
-
What Should Teens Ask Their Doctors About Hydroxyureahttps://www.youtube.com/watch?v=VZn15uXQ...
-
Desire for Parenthood and Reproductive Health Knowledge in Adolescents and Young Adults With Sickle Cell Disease and...Background/Objective: Sickle cell disea...
-
Developing Hydroxyurea, the First FDA-Approved Therapy for Sickle Cell Diseasehttps://www.youtube.com/watch?v=0kIz5ZKy...
-
The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occl...Introduction: The objective of this stu...
-
Children’s Hospital of WisconsinThe Sickle Cell Research Program at Chil...
-
FDA Clears Graphite Bio to Begin Trial for Gene Therapy in Sickle Cell DiseaseIn response to Graphite Bio’s investig...
